Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 71205-667

7 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 71205-667). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Oxybutynin Fig 1)

Figure 1 (Oxybutynin Fig 1)
A line graph depicting mean plasma concentration of R-Oxybutynin (ng/mL) over 24 hours. It compares oxybutynin extended release (ER) 10 mg once daily (QD) with oxybutynin 5 mg three times daily (TID), showing concentration changes at various time points throughout the day with error bars for variability.*
FDA Label Image

Figure 2 (Oxybutynin Fig 2)

Figure 2 (Oxybutynin Fig 2)
A line graph depicting the mean plasma concentration of R-Oxybutynin over time in hours, up to 24 hours. The y-axis represents concentration in ng/mL from 0.0 to 2.0, and the x-axis shows time from 0 to 24 hours. Data points show mean values with error bars indicating variability at multiple time intervals.*
FDA Label Image

Figure 3 (Oxybutynin Fig Study 1)

Figure 3 (Oxybutynin Fig Study 1)
A horizontal error bar chart illustrating mean change (±SD) in episodes per week from baseline for oxybutynin ER and placebo groups. The x-axis ranges from -40 to 40, showing data for oxybutynin ER trending below zero and placebo near zero.*
FDA Label Image

Figure 4 (Oxybutynin Fig Study 2)

Figure 4 (Oxybutynin Fig Study 2)
A horizontal bar chart showing mean change with standard deviation in episodes per week from baseline, comparing oxybutynin ER and oxybutynin. The x-axis ranges from -40 to 40. The chart visually presents data on the effect of oxybutynin chloride extended release tablets on episode frequency.*
FDA Label Image

Figure 5 (Oxybutynin Fig Study 3)

Figure 5 (Oxybutynin Fig Study 3)
A horizontal bar chart illustrating the mean change (±SD) in episodes per week from baseline for oxybutynin ER and oxybutynin. Values are shown along the x-axis ranging from -40 to 40, with oxybutynin ER showing a greater negative mean change compared to oxybutynin.*
FDA Label Image

71205-667-30 (Oxybutynin Lab 10mg)

71205-667-30 (Oxybutynin Lab 10mg)
Label for Oxybutynin Chloride 10 mg extended-release oral tablets by Proficient Rx LP. The label indicates a bottle containing 30 ER tablets, each with 10 mg of oxybutynin chloride. The tablets are pink, imprinted with "EM2" in black ink on one side. Manufactured by Intas Pharmaceuticals Limited, India.*
FDA Label Image

Chemical Structure (Oxybutynin Struc)

Chemical Structure (Oxybutynin Struc)
Chemical structure diagram of oxybutynin chloride, showing the molecular formula with characteristic functional groups and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.